Stephen Manning
Millennium Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen Manning.
Immunity | 2000
Anthony J. Coyle; Sophie Lehar; Clare Lloyd; Jane Tian; Tracy Delaney; Stephen Manning; Trang Nguyen; Tim Burwell; Helga Schneider; Jose Angel Gonzalo; Michael Gosselin; Laura Rudolph Owen; Christopher E. Rudd; Jose Carlos Gutierrez-Ramos
While CD28 is critical for expansion of naive T cells, recent evidence suggests that the activation of effector T cells is largely independent of CD28/B7. We suggest that ICOS, the third member of the CD28/CTLA-4 family, plays an important role in production of IL-2, IL-4, IL-5, and IFNgamma from recently activated T cells and contributes to T cell-dependent B help in vivo. Inhibition of ICOS attenuates lung mucosal inflammation induced by Th2 but not Th1 effector populations. Our data indicate a critical function for the third member of the CD28 family in T cell-dependent immune responses.
European Journal of Immunology | 2004
Susumu Okamoto; Hongbin Ji; Duncan Howie; Kareem Clarke; Charles Gullo; Stephen Manning; Anthony J. Coyle; Cox Terhorst
The SH2D1A gene, which is altered or deleted in patients with X‐linked lymphoproliferative disease, encodes the small protein SAP (for SLAM‐associated protein) that is expressed in T and NK cells. A 22‐bp fragment in close proximity to an initiator‐like site was defined as the basal promoter of mouse SH2D1A, and a highly homologous 33‐bp segment was defined as the human basal promoter. When an Ets consensus site was mutated, no reporter activity was detectable. Gel mobility supershift assays revealed that the two transcription factors Ets‐1 and Ets‐2 bind to the human and mouse sequences. The involvement of Ets‐1 and Ets‐2 in expression of SH2D1A was functionally confirmed by overexpression studies of their dominant‐negative forms. We also found that SH2D1A mRNA decays very rapidly in mouse T cells, and its 3′ untranslated region (UTR) has RNA‐destabilizing activity in transfection studies with reporter/3′ UTR constructs. As judged by RNA‐gel mobility shift assays, this rapid degradation of SH2D1A mRNA was due to a balance in binding of the factors AUF1 and HuR to its 3′ UTR. Although the SH2D1A mRNA level decreased upon triggering of the T cell receptor (TCR), the RNA degradation rate itself was not altered by TCR engagement.
Nature | 2002
Laurent Monney; Catherine A. Sabatos; Jason L. Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A. Greenfield; Anthony J. Coyle; Raymond A. Sobel; Gordon J. Freeman; Vijay K. Kuchroo
Blood | 2002
Duncan Howie; Susumo Okamoto; Svend T. Rietdijk; Kareem Clarke; Ninghai Wang; Charles Gullo; Joost P. Bruggeman; Stephen Manning; Anthony J. Coyle; Edward A. Greenfield; Vijay K. Kuchroo; Cox Terhorst
Archive | 2001
Anthony J. Coyle; Christopher C. Fraser; Stephen Manning
Archive | 1999
Anthony J. Coyle; Stephen Manning; Sophie Lehar; Jose-Carlos Gutierrez-Ramos
Archive | 2001
Anthony J. Coyle; Christopher C. Fraser; Stephen Manning
International Immunology | 2004
Ype P. de Jong; Svend T. Rietdijk; William A. Faubion; Ana Clara Abadía-Molina; Kareem Clarke; Emiko Mizoguchi; Jane Tian; Tracy Delaney; Stephen Manning; Jose Carlos Gutierrez-Ramos; Atul K. Bhan; Anthony J. Coyle; Cox Terhorst
Archive | 2000
Anthony J. Coyle; Christopher C. Fraser; Stephen Manning
Archive | 2003
Anthony J. Coyle; Christopher C. Fraser; Stephen Manning